Bristol-Myers Squibb Co. (BMY) PT Raised to $60 at HSBC

March 17, 2026 3:39 AM

HSBC analyst Rajesh Kumar raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $60.00 (from $53.00) while maintaining a Hold rating.

No results found